CPT added 94644 Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour and add-on code 94645 Continuous inhalation treatment with aerosol medication for acute ...
The designation was supported by data from the multicenter, double-blind, placebo-controlled phase 3 PROMIS-I study. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation ...
Self treatment of the respiratory tract using inhalation nebulizer. For a patient at high risk of severe Covid-19 related complications, newly released data shows that inhaled remdesivir offers the ...
The tentative approval cannot take effect because a competing product was granted market exclusivity. A new formulation of treprostinil (Yutrepia) could soon be available to patients with pulmonary ...
Please provide your email address to receive an email when new articles are posted on . Inhaled corticosteroids were associated with lower odds for mortality in patients with COPD. An eosinophil count ...
Ottawa, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The global inhaled therapy in respiratory disease market size is calculated at USD 11.98 billion in 2025 and is expected to reach around USD 16.22 billion by ...
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
A study finds that IN-006, a reformulated monoclonal antibody, is safe, well-tolerated, and delivers high antibody levels in the airway—offering a faster and more effective way to fight COVID-19.
This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China. Objectives: This study aimed to evaluate ...
Researchers found that high-dose inhaled nitric oxide reduced Pseudomonas auruginosa burden and preclinical studies ...
A new study from North Carolina State University shows that lung stem cell secretions - specifically exosomes and secretomes - delivered via nebulizer, can help repair lung injuries due to multiple ...